# Soligenix Inc. (NASDAQ: SNGX) Research Highlights Breakthrough in High-Temperature Vaccine Stability

* Thermostable vaccine technology is considered a significant unmet need in epidemic preparedness.
* Soligenix has been developing formulations intended to remain stable even when stored for extended periods at temperatures above 40°C.
* Soligenix’s ThermoVax(R) technology has broad applicability in Emerging Infectious Disease.

 Current vaccines for Ebola and similar filoviruses face a major deployment barrier: Most require storage between 2°C and 8°C throughout transport, making them vulnerable to spoilage when exposed to the high ambient heat common in many outbreak regions (https://ibn.fm/MZWfk). Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company specializing in biodefense and rare disease vaccines, has published a peer-reviewed summary of new scientific data demonstrating long-term high-temperature stability of its protein subunit vaccine platform designed for Ebola and Marburg-related viruses (https://ibn.fm/F2JpN).

 The World Health Organization estimates that more than 50% of vaccine doses globally are wasted each year due to breakdown in the cold chain, driven largely by inadequate temperature control during transport and storage (https://ibn.fm/WJsm6). Studies report that live-attenuated and recombinant…

 Read More>>

 NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX

 About BioMedWire

 BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

 BMW is where breaking news, insightful content and actionable information converge.

 To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

 For more information, please visit https://www.BioMedWire.com

 Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

 BioMedWireSan Francisco, CAwww.BioMedWire.com415.949.5050 OfficeEditor@BioMedWire.com

 BioMedWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/bmw/soligenix-inc-nasdaq-sngx-research-highlights-breakthrough-in-high-temperature-vaccine-stability/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/soligenix-breakthrough-heat-stable-ebola-vaccine-defies-cold-chain-limits/0d6e48b851ec06fe5332df71e01c53a3) 


Pickup - [https://burstable.news/news](https://burstable.news/news/202510/267686-soligenix-thermostable-vaccine-technology-addresses-critical-cold-chain-limitations)

Pickup - [https://estallarnoticias.com/](https://estallarnoticias.com//202510/267622-soligenix-desarrolla-tecnologia-de-vacunas-termoestables-para-combatir-enfermedades-infecciosas-emergentes)

Pickup - [https://platzennachrichten.de/nachrichten](https://platzennachrichten.de/nachrichten/202510/267659-soligenix-forschung-zeigt-durchbruch-bei-hitzestabilen-impfstoffen-gegen-ebola-und-marburg)

Pickup - [https://actueclair.com](https://actueclair.com/202510/267640-soligenix-demontre-une-avancee-majeure-dans-la-stabilite-des-vaccins-a-haute-temperature)
 

 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/2510/28/healHJ8l.webp)